Adial Pharmaceuticals, Inc. (ADIL) vs Pluri Inc. (PLUR)
A side-by-side comparison of Adial Pharmaceuticals, Inc. and Pluri Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADIL
Adial Pharmaceuticals, Inc.
$4.16HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
PLUR
Pluri Inc.
$1.03HealthcareDelayed quote: Oct 6, 2026, 3:22 PM EDT
Total return — ADIL vs PLUR
growth of $100 · dividends reinvested · last 8yADIL -99.8% (-54.9%/yr)PLUR -99.0% (-43.8%/yr)PLUR compounded faster over this window
Log scale — wide-divergence pair
ADIL PLUR
ADIL vs PLUR: by the numbers
- •PLUR is the larger company ($11M vs $11M market cap).
- •Both run net losses; ADIL's is the smaller (0.00% vs -2406.00% net margin).
Metrics side by side
Valuation
| Metric | ADIL | PLUR |
|---|---|---|
| P/S ratio | N/A | 10.89 |
Profitability
| Metric | ADIL | PLUR |
|---|---|---|
| Gross margin | 0.00% | 44.59% |
| Operating margin | 0.00% | -2455.91% |
| Net margin | 0.00% | -2406.00% |
| ROE | -37052.06% | N/A |
| ROIC | -240.64% | -127.37% |
Growth (annualized)
| Metric | ADIL | PLUR |
|---|---|---|
| Total return CAGR (5Y) | -71.86% | -44.78% |
Frequently asked
- How have ADIL and PLUR total returns compared?
- Over the past 5 years, ADIL delivered -71.86% and PLUR delivered -44.78% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.